DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension

Name: DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension
License: Public Domain

Gilead Sciences

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

hypertension

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 152558
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.